Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New mRNA tech takes aim at the flu

NCT ID NCT06431607

Summary

This study tested a new seasonal flu vaccine made with mRNA technology, similar to some COVID-19 vaccines. It involved 845 healthy adults to see how well their immune systems responded to different doses of the vaccine and to check for side effects. The goal was to gather data to see if this new type of flu shot is safe and effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • GSK Investigational Site

    Hialeah, Florida, 33012, United States

  • GSK Investigational Site

    Miami, Florida, 33147, United States

  • GSK Investigational Site

    Miami, Florida, 33186, United States

  • GSK Investigational Site

    Chicago, Illinois, 60640, United States

  • GSK Investigational Site

    Valparaiso, Indiana, 46383, United States

  • GSK Investigational Site

    El Dorado, Kansas, 67042, United States

  • GSK Investigational Site

    Lenexa, Kansas, 66219, United States

  • GSK Investigational Site

    Newton, Kansas, 67114, United States

  • GSK Investigational Site

    Wichita, Kansas, 67207, United States

  • GSK Investigational Site

    Lexington, Kentucky, 40509, United States

  • GSK Investigational Site

    Rochester, New York, 14609, United States

  • GSK Investigational Site

    Greensboro, North Carolina, 27408, United States

  • GSK Investigational Site

    Knoxville, Tennessee, 37909, United States

  • GSK Investigational Site

    Austin, Texas, 78705, United States

  • GSK Investigational Site

    Fort Worth, Texas, 76135, United States

  • GSK Investigational Site

    Tomball, Texas, 77375, United States

  • GSK Investigational Site

    Newport News, Virginia, 23606, United States

  • GSK Investigational Site

    Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.